Anupam Rasayan India Ltd (NSE:ANURAS)
India · Delayed Price · Currency is INR | Market Cap | 141.59B +8.3% |
| Revenue (ttm) | 25.35B +52.4% |
| Net Income | 1.75B +41.5% |
| EPS | 15.11 +36.9% |
| Shares Out | 113.85M |
| PE Ratio | 82.28 |
| Forward PE | 45.08 |
| Dividend | 1.50 (0.12%) |
| Ex-Dividend Date | Jul 21, 2025 |
| Volume | 436,272 |
| Open | 1,240.00 |
| Previous Close | 1,239.40 |
| Day's Range | 1,233.50 - 1,251.00 |
| 52-Week Range | 1,045.20 - 1,415.00 |
| Beta | 0.11 |
| Analysts | Hold |
| Price Target | 1,215.71 (-2.25%) |
| Earnings Date | Aug 14, 2026 |
About Anupam Rasayan India
Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediat... [Read more]
Financial Performance
In fiscal year 2026, Anupam Rasayan India's revenue was 23.65 billion, an increase of 64.61% compared to the previous year's 14.37 billion. Earnings were 1.70 billion, an increase of 82.24%.
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for ANURAS stock is "Hold." The 12-month stock price target is ₹1,216, which is a decrease of -2.25% from the latest price.
News
Anupam Rasayan India commercialises ETFA using flow chemistry, a global first
Anupam Rasayan India Ltd. has announced the commercialisation of ETFA (Ethyl trifluoroacetate) production through its proprietary continuous flow chemistry platform. This marks a global first in the c...
Anupam Rasayan makes Rs 299 per share open offer for Bliss GVS Pharma
Anupam Rasayan India Limited has announced an open offer to acquire up to 2,77,26,848 fully paid-up equity shares of Bliss GVS Pharma Limited at a price of ₹299 per share.…
Bliss GVS Pharma faces Rs 299 per share open offer from Anupam Rasayan
Bliss GVS Pharma Limited is the target of an open offer from Anupam Rasayan India Limited, which seeks to acquire up to 2,77,26,848 fully paid-up equity shares. This represents 26%…
Anupam Rasayan India acquires up to 48.2% stake in Bliss GVS Pharma
Anupam Rasayan India Ltd. has announced a significant acquisition, entering into a definitive agreement to acquire a 43.3-48.2% equity stake in Bliss GVS Pharma Limited. The acquisition also includes ...
Anupam Rasayan India to acquire up to 48.2% stake in Bliss GVS Pharma
Anupam Rasayan India Ltd. has announced its entry into a definitive agreement to acquire a 43.3-48.2% equity stake in Bliss GVS Pharma Limited. The acquisition also includes an open offer…
Anupam Rasayan reports 65% revenue growth in FY26, driven by strategic expansions
Anupam Rasayan India Ltd., a leading player in custom synthesis and specialty chemicals, has reported a significant 65% year-on-year increase in total revenue for the financial year ending March 31,…
Anupam Rasayan announces resignation of Deputy CFO Vishal Thakkar
Anupam Rasayan India has announced the resignation of its Deputy Chief Financial Officer (CFO) and Key Managerial Personnel, Mr. Vishal Thakkar, effective immediately from May 23, 2026. The company di...
Anupam Rasayan to acquire up to 74.20% stake in Bliss GVS Pharma for Rs 1,369 crore
Anupam Rasayan India has announced its board's approval for acquiring up to 74.20% of Bliss GVS Pharma's equity shares. The acquisition will be executed through a share purchase agreement and…
Anupam Rasayan to acquire 74.20% stake in Bliss GVS Pharma for Rs 1,369 crore
Anupam Rasayan India has announced its intention to acquire a significant stake in Bliss GVS Pharma, a move designed to bolster its presence in the pharmaceutical sector. The acquisition involves…
Anupam Rasayan India Ltd At US Acquisition Update Call Transcript
Anupam Rasayan India Ltd At US Acquisition Update Call Transcript
Anupam Rasayan signs definitive agreement to acquire U.S.-based Jayhawk Fine Chemicals Corporation
Anupam Rasayan India Ltd. has announced that it has signed a definitive agreement to acquire 100% equity stake in Jayhawk...
Anupam Rasayan approves acquisition of Monitchem Kansas S.à r.l and subsidiaries for up to USD 155 million
Anupam Rasayan India Ltd has announced a major overseas acquisition as its Board, in a meeting held on December 9,...
Why are Anupam Rasayan shares falling 5% from day high? Explained
Shares of Anupam Rasayan India Ltd slipped nearly 5% from the day’s high, even after the company reported strong Q2...
Anupam Rasayan Q2 FY26 results: Revenue surges 149% YoY to Rs 731 crore; net profit rises 166% YoY
Anupam Rasayan India Limited reported strong financial results for the quarter ended September 30, 2025 (Q2 FY26), with a sharp...
Anupam Rasayan declares interim dividend – Know More
Anupam Rasayan India Ltd. (ARIL) on Tuesday, July 15, announced several key decisions following its board meeting. The company declared an interim dividend, approved a preferential allotment of equity...
Anupam Rasayan signs LOI with E-Lyte and FUCHS Lubricants Germany for long-term electrolyte salt supply
Anupam Rasayan India Ltd. has entered a new strategic domain with the signing of a Letter of Intent (LOI) with Germany-based E-Lyte Innovations GmbH and FUCHS Lubricants Germany GmbH. This collaborati...
Anupam Rasayan India shares jump over 3% as Q4 EBITDA rises 55.70% YoY to Rs Rs 144.3 crore
Anupam Rasayan India saw its shares rise by over 3% in morning trading following the release of its Q4 FY25 consolidated financial results. As of 9:52 AM, the shares were trading 3.88% higher at Rs 97...
Anupam Rasayan signs above Rs 900 crore LoI with leading Korean MNC
Anupam Rasayan India Ltd. (NSE: ANURAS, BSE: 543275), a leading player in custom synthesis and specialty chemicals, has secured a significant 10-year letter of intent (LOI) valued at $106 million (₹92...
Anupam Rasayan signs LOI with Elementium Materials for supply of advanced solvent for EV batteries
Anupam Rasayan India Ltd, one of the leading specialty chemicals manufacturers, has signed a Letter of Intent (LOI) with U.S.-based Elementium Materials Inc. to supply essential chemicals for an advan...